We are committed to embracing, promoting and embedding scientific and technical best practice in animal research.
In 2013, AstraZeneca used 260,930 animals in-house (304,751 in 2012). In addition, 19,676 animals were used by external contract research organisations on our behalf (14,284 in 2012). Around 91% of the animals used in 2013 were rodents, 8% were fish and the remaining 1% included ferrets, primates, dogs, chickens, rabbits, pigs, and sheep. We also used genetically modified mice and rats to understand better the genes involved in human disease. In 2013, these accounted for approximately 6% of our total rodent use.
The number of animals we use will continue to vary because it depends on a number of factors including the amount of pre-clinical research we are doing, the complexity of the diseases under investigation and the regulatory requirements.
Consistent standards internally/externally
100% of our internally and externally placed animal studies are meeting AstraZeneca standards which are based on the principles of the 8th Edition of the Guide for the Care and Use of Laboratory Animals (“the Guide”) or the legislative or administrative controls that apply in the region where the work is being conducted, whichever is the higher or more stringent standard.
Go back to...
We are committed to the responsible use of animals and the welfare of the animals we use is a top priority.Read more
Our top priority is to make sure that that those taking part in our studies are not exposed to any unnecessary risks.Read more